<DOC>
<DOCNO>
EP-0017322
</DOCNO>
<TEXT>
<DATE>
19801015
</DATE>
<IPC-CLASSIFICATIONS>
C08B-37/00 C12P-19/04 C12P-19/00 <main>A61K-39/02</main> A61K-39/09 C12R-1/46 C12P-19/26 
</IPC-CLASSIFICATIONS>
<TITLE>
stabilization of capsular polysaccharides.
</TITLE>
<APPLICANT>
american cyanamid cous<sep>american cyanamid company<sep>american cyanamid companyberdan avenue wayne new jersey 06904 us <sep>american cyanamid company<sep>
</APPLICANT>
<INVENTOR>
cano francis robert<sep>querry merle vernon<sep>cano, francis robert<sep>querry, merle vernon<sep>cano, francis robert166 summit park roadspring valley, new yorkus<sep>querry, merle vernon707 rivervale roadriver vale, new jerseyus<sep>cano, francis robert  <sep>querry, merle vernon<sep>cano, francis robert166 summit park roadspring valley, new yorkus<sep>querry, merle vernon707 rivervale roadriver vale, new jerseyus<sep>
</INVENTOR>
<ABSTRACT>
labile capsular polysaccharides, such as type-19  pneumococcal capsular polysaccharide, are stabilized  against degradation during the lyophilization step which  forms a part of the procedure for recovering the capsular  polysaccharide from the fermentation in which it has been  produced, by adding an amphoteric substance, such as a  protein or amino acid, prior to the lyophilization.  
</ABSTRACT>
</TEXT>
</DOC>
